Results 171 to 180 of about 150,543 (314)
BOOST 2.0: Feasibility of Using the Nursing Student Workforce to Increase Activity: A Qualitative Study. [PDF]
Darmali A +9 more
europepmc +1 more source
Effectiveness of feedback type on performance quality and satisfaction of nursing student: A comparative interventional study. [PDF]
Imanipour M, Mirzaeipour F, Hazaryan M.
europepmc +1 more source
ABSTRACT Management of cerebral vasculopathy in sickle cell anemia (SCA) includes standard‐care, that is, chronic transfusion (CT) or hydroxyurea, and hematopoietic cell transplantation (HCT). DREPAGREFFE‐1 (December 2010/June 2013), a French multicenter trial, was the first prospective trial comparing standard‐care to match sibling donor (MSD)‐HCT in ...
Francoise Bernaudin +40 more
wiley +1 more source
2018-2019 Nursing Undergraduate Student Handbook
2018-2019 Undergraduate Student Handbook of the Department of Nursing at Morehead State ...
Morehead State University. Nursing Department.
core
The Nursing Student Licensure Examination: A Scoping Review. [PDF]
Pantaleo F +7 more
europepmc +1 more source
ABSTRACT Limited data exist on how patients and physicians perceive immune thrombocytopenia (ITP) symptoms and treatment‐related burden. I‐WISh (ITP World Impact Survey) 2.0 surveyed 1018 patients and 431 physicians in 15 countries to characterize the impact of ITP and its treatments on patients.
Nichola Cooper +17 more
wiley +1 more source
Pre-Registration Nursing Student Experiences of International Mental Health Clinical Placement: A Scoping Review With Relevance to the Australian Context. [PDF]
Wilson A, Molloy R, Searby A.
europepmc +1 more source
Approach to advanced practice nursing student clinical during COVID-19. [PDF]
McIltrot K +3 more
europepmc +1 more source
ABSTRACT Mosunetuzumab plus polatuzumab vedotin has shown promising activity versus rituximab plus polatuzumab vedotin (R‐Pola) in patients with relapsed/refractory (R/R) large B‐cell lymphoma (LBCL; NCT03671018). We present results from the Phase II randomized cohort, evaluating subcutaneous mosunetuzumab plus polatuzumab vedotin (Mosun‐Pola), with ...
Julio C. Chavez +17 more
wiley +1 more source

